PharmaVentures Appoints Samara Ferguson as Vice President to Lead Pricing and Market Access Team
Comunicato Precedente
Comunicato Successivo
Samara's consultancy experience also brings many years of insight across numerous therapy areas, where she rigorously pressure-tested market access and price potential, developed market access strategies, evidence generation plans, and bespoke real-world studies.
Samara has also supported rapid assessments of in-licensing opportunities to identify key areas of risk and opportunities and inform investment decision-making.
Dr Fintan Walton, Founder andCEO of PharmaVentures, said: "We are delighted to welcome Samara to the PharmaVentures team. Her 20+ extensive years of experience working for major pharma and advising numerous small to mid-sized pharma will be an enormous benefit to our clients, who need high-quality pricing and market access support in due diligence and negotiating the right terms for their deals."
Samara holds a MSc in Health Economics and Health Policy from the University of Birmingham.
For further information, please contact:
Rachel Hampstead
[email protected]
Logo - https://mma.prnewswire.com/media/2703310/5399710/PV_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/pharmaventures-appoints-samara-ferguson-as-vice-president-to-lead-pricing-and-market-access-team-302497603.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom




